Differential protein stability of EGFR mutants determines responsiveness to tyrosine kinase inhibitors.
Ray P, Tan YS, Somnay V, Mehta R, Sitto M, Ahsan A, Nyati S, Naughton JP, Bridges A, Zhao L, Rehemtulla A, Lawrence TS, Ray D, Nyati MK.
Ray P, et al. Among authors: ray d.
Oncotarget. 2016 Oct 18;7(42):68597-68613. doi: 10.18632/oncotarget.11860.
Oncotarget. 2016.
PMID: 27612423
Free PMC article.